Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01978912 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
A Phase 1 study, sponsored by Teijin America.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT01978912 is a Phase 1 study that has completed, run by Teijin America. The registered enrollment target is 24 participants.
The verdict
NCT01978912, a Phase 1 study, has completed, sponsored by Teijin America.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and exploratory efficacy of KTP-001 in subjects with lumbar disc herniation.
Interventions
- DRUG KTP-001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-02 |
| Est. Completion | 2018-10-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01978912
The ClinicalTrials.gov registry entry for NCT01978912 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teijin America, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which KTP-001 is the first listed.
NCT01978912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01978912 about?
NCT01978912 is a clinical study titled "A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation". The purpose of this study is to evaluate the safety and exploratory efficacy of KTP-001 in subjects with lumbar disc herniation.
What is the current status of trial NCT01978912?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2013-02. Estimated completion is 2018-10-16.
What interventions are being tested in trial NCT01978912?
The interventions under investigation include: KTP-001 (DRUG).
Who is sponsoring clinical trial NCT01978912?
This trial is sponsored by Teijin America, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.